After two years of virtual conferences, the ATS 2022 International Conference will be live and in-person and DelveInsight is attending the conference extensively. Each year, nearly 14k+ of these professionals across the globe choose to attend and present, and DelveInsight will learn from these researchers and experts and will try to implement all the findings in its reports. Clinicians and researchers in many other fields attend the conference, thereby enriching conversations that lead to insights that ultimately improve patient care.
ATS International Conference is a platform connecting various pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. DelveInsight is pleased to attend this prestigious event in order to cover the vast indication topics specifically related to improving respiratory health globally. In this multifaceted event, a large number of abstracts will be presented and discussed from multiple perspectives by clinicians and researchers which will benefit DelveInsight for its upcoming reports.
Let’s Connect On A One-To-One Meeting At The ATS International Conference 2022.
Join DelveInsight from May 25, 2022 simply by filling up the form towards the right.
DelveInsight’s Market Intelligence services focus on providing indication-based reports that are tailored to the client's specific geography of interest. We have a specialized vast repository of Respiratory and Pulmonary diseases market including ready reports of COPD, Asthma, Acute Lung Injury, ARDS, Cystic Fibrosis, Dyspnea, Tuberculosis, Obstructive Sleep Apnea as well as rare pulmonary diseases such as Pulmonary Fibrosis, Lymphangioleiomyomatosis, and many more.
DelveInsight’s Pulmonology Portfolio Management services provide exceptionally unmatched assistance in understanding competencies in the pulmonology, critical care, and sleep disorder market. In addition to that, we prioritize strategic goals, assess the changes in the healthcare industry, understand the current needs of the pulmonology, and sleep disorder market and likewise work on creating value for client services.
Our multidimensional, purposeful, and credible consultancy services will help in accelerating pulmonology, critical care, and sleep disorder product services, it includes aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, diagnostic landscape assessment to overcome several challenges in the pulmonology, critical care, and sleep disorder market.
We have a specialized primary Competitive Intelligence research team that has expertise in the field of pulmonology. It constitutes analysts, senior analysts, and managers. Our CI force provides the best possible opportunities and most accurate intelligence that can be accumulated and provide to our partners. In addition, exceptionally well and a collection of data with a fundamental goal of acquiring best-in-class intelligence and providing pulmonolgy analysis with respect to different pulmonary therapeutics to achieve the consultation goal of our partners.
Our research and development analyst understands the pulmonolgy realm to create value based decisions and help clients achieve better pulmonolgical R&D endeavors. Any pulmonolgical drug's journey through pre-clinical and clinical development is done by assessing the same parameters of other candidates already in the space. Similar is done for the pulmonolgy drugs as well. DelveInsight’s insight-packed pulmonolgical reports provide clarity on uncertainties and challenge blind spots to provide timely intelligence to the company.
DelveInsight’s Pulmonolgical Pipeline Assessment promises an overarching view of lung disease therapies, their clinical trials, as well as each and every highlight of pulmonolgy therapeutics landscape in a report format. Encompassing ready reports already present in our Report Store, our Pipeline Assessment report type provides insights across therapies, MoAs, Drugs, APIs, as well as Launch Insights of drugs in late stage of development to provide understanding of their launch timelines and strategies.
DelveInsight’s Epidemiological Analysis reports encompass historical and forecasted disease epidemiology covering several geographies. DelveInsight’s exceptionally capable forecasting team covers global epidemiology trends revolving around respiratory and pulmonary disorders providing insights into the historical and forecasted patient pool, helping recognize our clients the growth opportunities in the coming years. Several epidemiology reports related to pulmonary diseases encapsulate indications such as Bronchiolitis Obliterans Syndrome, Chronic Insomnia, Bronchial Spasm, Chronic Cough, Cystic fibrosis, Sleep Apnea, Allergic Rhinitis, and several others. We are able to serve epidemiology analysis for coverage across many geographies specified to the client's area of interest.
We welcome you to discuss your business-related concerns and we can together find the best possible solution to help you proceed further in the Biotechnology and Pharma market.
Ms. Cheryl Anne Branches has managerial experience of more than 10 years in providing strategic decision support to top global pharmaceuticals. She holds exceptional experience in project management and business development, having worked with cross-cultural teams. Her expertise lies in the field of Commercial Analytics and Sales Force Effectiveness. Schedule a meeting today with Cheryl to discuss how DelveInsight’s Consulting portfolio steers your company towards success!
The ATS International Conference, 2022 conference and exhibition in the very pleasant venue - The Moscone Center in the city of San Francisco, California.
